Immunohistochemical characteristics of collagen I, III, IV type deposition in the dynamics of progressing of the basic types of liver fibrosis in patients with non-alcohol steatohepatitis.

Authors

  • S. V. Fen’ Zaporizhzhia State Medical University, Ukraine

DOI:

https://doi.org/10.26641/1997-9665.2017.3.29-38

Keywords:

nonalcoholic steatohepatitis, liver fibrosis, collagen.

Abstract

Background. The study of patterns of collagen deposition of various types in the dynamics of hepatic fibrosis progression is essential to the development of targeted therapy for liver fibrosis in patients with nonalcoholic and alcoholic steatohepatitis. Objective. The aim is to study the area of deposition of collagen I, III and IV type in the dynamics of the progression of F1 - F3 perisinusoidal-pericellular and portal-perisinusoidal fibrosis in F4 liver cirrhosis of micronodular and pericellular type in hepatotrepanobioptates of patients with nonalcoholic steatohepatitis, using the methods of immunohistochemistry. Methods. The immunohistochemical studies are conducted in liver trepanobioptates in 80 patients with perisinusoidal pericellular and portal perisinusoidal fibrosis of varying severity. Results. It is found that the deposition of type I, III and IV collagen increases with the development and progression of fibrosis from F1 – the weak grade, to F2 –the moderate grade and F3 to severe grade of fibrosis in the liver. With the progression of perisinusoidal pericellular and portal perisinusoidal fibrosis, the increase in type III collagen deposition decreases. In F4 liver fibrosis/cirrhosis of the pericellular type, the deposition of type I and IV collagen reaches a maximum, the area of deposition of type I collagen is more than 50% greater than the deposition area of type III collagen. In F4 fibrosis/cirrhosis of the portal perisinusoidal type, the deposition area of type I collagen also reaches a maximum, while the collagen storage area of type III and IV stabilizes at the level of severe F3 of liver fibrosis. Conclusion. In patients with nonalcoholic steatohepatitis, the quantitative ratios of different types of collagen in the zones of perisinusoidal pericellular and portal perisinusoidal fibrosis change dynamically as the hepatofibrosis increase and its transformation into liver cirrhosis.

References

  1. Singh S, Allen AM, Wang Zh, Prokop LJ, Murad MH, Loomba R. Fibrosis progression in non-alcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies. Clin Gastroenterology and Hepatology. 2015;13(4):643-54. doi: 10.1016/j.cgh.2014.04.014
  2. Wells RG. The portal fibroblast: not just a poor man's stellate cell. Gastroenterology. 2014;174(1):41-7. doi: 10.1053/j.gastro.2014.05.001.
  3. Xu J, Liu X, Koyama Y, Wang P, Lan T, Kim IG, Kim IH, Ma HY, Kisseleva T. The types of hepatic myofibroblasts contributing to liver fibrosis of different etiologies. Front Pharmacol. 2014;22(5):167-79. doi: 10.3389/fphar.2014.00167.
  4. Baiocchini A, Montaldo C, Conigliaro A, Grimaldi A, Correani V, Mura F, Ciccosanti F, Rotiroti N, Brenna A, Montalbano M, D’Offizi D, Capobianchi MR, Alessandro R, PiacentiniM, Schininà ME, Maras B, Nonno F, Tripodi M, Mancone C. Extracellular matrix molecular remod-eling in human liver fibrosis evolution. PLoS ONE. 2016;11(3):1-14. doi:10.1371/journal.pone.0151736.
  5. Iredale JP, Thompson A, Henderson NC. Ex-tracellular matrix degradation in liver fibrosis: bio-chemistry and regulation. Biochimica et Biophysica Acta. 2013;1832(7):876–83. doi: 10.1016/j.bbadis.2012.11.002.
  6. Brunt EM, Kleiner DE, Wilson LA, Belt P, Neuschwander-Tetri BA. Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings. Hepatology. 2011;53(3):810–20. doi: 10.1002/hep.24127.
  7. Monga SPS; Wells RG. Hepatic fibrosis and cirrhosis in: molecular pathology of liver diseases (repr.) Pittsburgh (USA): Springer Science+Business Media; 2011. Ch.30. 931р. doi 10.1007/978-1-4419-7107-4-30.
  8. Bedossa P. FLIP Pathology Consortium. Utility and appropriateness of the fatty liver inhibi-tion of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease. Hepatology. 2014;60(2):565-75. doi:10.1002/hep.27173.
  9. Kleiner DE, Brunt EM, Natta M, Behling C, Contos MJ, Cummings O W, Ferrell LD, Liu YC, Torbenson MS, Unalp-Arida A, Yeh M, McCullough AJ, Sanyal AJ. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41(6):1313–21. doi: 10.1002/hep.20701.
  10. Burt AD, Portmann BC, Ferrell LD. MacSween’s Pathology of the Liver. 6th (enl.) New York (USA): Churchill livingstone Elsevier; 2012. 1020 p.
  11. Hernandez-Gea V, Friedman SL. Pathogen-esis of liver fibrosis. Annu Rev Pathol. 2011;6:425–56. doi: 10.1146/annurev-pathol-011110-130246.
  12. Hui AY, Friedman SL; Dufour JF, Clavien РА, Trautwein Сh, Graf R. Extracellular Matrix Signaling Pathways in Liver Diseases. 3rd (enl.) Pittsburgh (USA): Springer; 2005. Ch.6. 63-71.
  13. Mak KM, Chu E, Lau KH, Kwong AJ. Liver fibrosis in elderly cadavers: localization of collagen types I, III and IV, α-smooth muscle actin, and elastic fibers. Anat Rec. 2012; 295(7):1159–67. doi: 10.1002/ar.22504.
  14. Bedossa P, Poitou C, Veyrie N, Bouillot JL, Basdevant A, Paradis V, Tordjman J, Clement K. Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese pa-tients. Hepatology. 2012;56(5):1751–9. doi: 10.1002/hep.25889.
  15. Ferrell L. Liver Update on Staging of Fi-brosis and Cirrhosis. 2013 [el.res. http://labmed.ucsf.edu/uploads/472/227_Ferrell,%20LiverUpdateOnStagingOfFibrosisAndCirrhosis.pdf].
  16. Wang L, Shuangni Yu, Chan AW. Patholo-gy of non-alcoholic fatty liver disease. Int J Dig Dis. 2016;2(1):1-7. doi:10.4172/2472-1891.100014.
  17. Suk KT, Kim DJ. Staging of liver fibrosis or cirrhosis: The role of hepatic venous pressure gradient measurement. World J Hepatol. 2015;7(3):607–15.
  18. Monteiro JM, Monteiro GM, Caroli-Bottino A, Pannain VL. Nonalcoholic fatty liver disease: different classifications concordance and relation-ship between degrees of morphological features and spectrum of the disease. Anal Cell Pathol. 2014;526979:1-6. doi: 10.1155/2014/526979.
  19. Chen W, Rock JB, Yearsley MM, Ferrell LD, Frankel WL. Different collagen types show dis-tinct rates of increase from early to late stages of hepatitis C–related liver fibrosis. Hum Pathol. 2014;45(1):160–5.

Downloads

How to Cite

Fen’, S. V. (2017). Immunohistochemical characteristics of collagen I, III, IV type deposition in the dynamics of progressing of the basic types of liver fibrosis in patients with non-alcohol steatohepatitis. Морфологія / Morphologia / Morfologìâ, 11(3), 29–38. https://doi.org/10.26641/1997-9665.2017.3.29-38

Issue

Vol. 11 No. 3 (2017)

Section

Статті

License

Copyright (c) 2018 Morphologia

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

 The authors reserve the right to authorship of their work and transfer to the Journal the right to the first publication of this work under the terms of a license Creative commons Attribution 4.0 International (CC BY 4.0), which allows other people to freely distribute the published work with a mandatory reference to the authors of the original work and the first publication of the work in this journal.
        By submitting a manuscript to the editorial office of the Journal ‘Morphologia’ authors agree to transfer the rights to protect and use the manuscript (all supplemental materials, particularly protected objects such as photos, drawings, diagrams, tables, etc.), including the reproduction in the press and distribution via the Internet; translation of the manuscript into any language; export and import of journal copies with the Authors’ article in order to make it available for public. Authors convey the rights mentioned above to the editorial office without any temporal or territorial limitation all over the world. 
        The Authors guarantee that they have the exclusive rights to use the material transferred to editorial office. Editors are not responsible to third parties for contraventions of warranty given by the Authors. The considered rights are transferred to the editorial office since the moment when the current issue is signed for publishing. Reproduction of materials published in the Journal by other individuals and legal entities is possible only with the consent of Editorial office, with the obligatory indication of the full bibliographic reference of the primary publication. The Authors reserve the right to use the published material, its fragments and parts for teaching materials, oral presentations, dissertation thesis prepararion with obligatory bibliographic citation of the original paper. Electron copy of the published article, downloaded from official journal web-site in .pdf format may be put by authors on the official web-site of their institutions, any other official resources with open access.